Curto-Barredo, LaiaDuran Jordà, Xavier, 1974-Giménez Arnau, Anna Maria2018-10-222018Curto-Barredo L, Spertino J, Figueras-Nart I, Expósito-Serrano V, Guilabert A, Melé-Ninot G. et al. Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticarial. Br J Dermatol. 2018 Jul;179(1):210-212. DOI: 10.1111/bjd.163790007-0963http://hdl.handle.net/10230/35625application/pdfengThis is the pre-peer reviewed version of the following article: urto-Barredo L, Spertino J, Figueras-Nart I, Expósito-Serrano V, Guilabert A, Melé-Ninot G. et al. Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticarial. Br J Dermatol. 2018 Jul;179(1):210-212., which has been published in final form at http://dx.doi.org/10.1111/bjd.16379. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.Urticària -- TractamentOmalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticariainfo:eu-repo/semantics/articlehttp://dx.doi.org/10.1111/bjd.16379info:eu-repo/semantics/openAccess